Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
about
Osteoporosis in liver disease: pathogenesis and managementImpact of hepatitis C virus infection on bone mineral density in renal transplant recipientsVitamin D status and viral response to therapy in hepatitis C infected children.Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infectionEffects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsIn HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients.Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys.HIV and Bone Complications: Understudied Populations and New Management Strategies.Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting AntiviralsImpact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C.Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients.Suboptimal Level of Bone-Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy
P2860
Q26746935-29F0F657-3DCB-4814-A573-332F0F809817Q28487941-6B8C1E4F-F9AC-4F18-A017-C8CA1E37E333Q35012136-58D5642E-D68B-4D6C-A247-C4E351E9E8A7Q35040559-675C6F77-84FE-4A4B-9079-1446A1E01B81Q36756136-0F27AE12-88A3-43FA-8641-BE655F2762D8Q37016495-FF38707A-AE24-4BEE-AE91-8E28BBBD0F19Q37085238-5AA2D9C5-18D7-4CB6-9DD0-E33AA2A9E1EDQ37741812-A8B5370D-FC87-47A5-80EB-6DB58DBEB385Q38738823-3CD2EAA5-88DE-4DF1-BC86-CDA5B0CD2440Q38911526-7DA3609F-EB27-4D0C-B484-648C6DA7C94FQ38978479-886A986A-878A-40B0-8EBB-5D78983AA99AQ40225926-2C3F7525-1F56-467C-B5F9-737A123AAD4AQ40621942-DD03E981-3AAF-4825-BD53-905DF6392B21Q42260234-FDE3944F-DF16-4F83-BD3B-A4A4AC7892ACQ42992125-97B3153E-6989-4D5C-A2FD-2E340EF6F35AQ58765036-D9B4EE97-3304-4D71-8A91-216187FC2FBD
P2860
Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Virus clearance reduces bone f ...... e caused by hepatitis C virus.
@en
Virus clearance reduces bone f ...... e caused by hepatitis C virus.
@nl
type
label
Virus clearance reduces bone f ...... e caused by hepatitis C virus.
@en
Virus clearance reduces bone f ...... e caused by hepatitis C virus.
@nl
prefLabel
Virus clearance reduces bone f ...... e caused by hepatitis C virus.
@en
Virus clearance reduces bone f ...... e caused by hepatitis C virus.
@nl
P2093
P356
P1476
Virus clearance reduces bone f ...... se caused by hepatitis C virus
@en
P2093
Fumitaka Suzuki
Hiromi Yatsuji
Hiromitsu Kumada
Hiroshi Tsuji
Hisahito Kato
Hitomi Sezaki
Kazuhisa Amakawa
Kenji Ikeda
Masahiro Kobayashi
Miharu Hirakawa
P2860
P304
P356
10.1002/JMV.21691
P577
2010-03-01T00:00:00Z